ICON EBITDA Margin 2010-2024 | ICLR

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ICON (ICLR) over the last 10 years. The current EBITDA margin for ICON as of September 30, 2024 is .
ICON EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $8.31B $1.61B 19.40%
2024-06-30 $8.33B $1.64B 19.67%
2024-03-31 $8.23B $1.62B 19.62%
2023-12-31 $8.12B $1.54B 18.99%
2023-09-30 $8.02B $1.48B 18.49%
2023-06-30 $7.90B $1.45B 18.33%
2023-03-31 $7.82B $1.42B 18.11%
2022-12-31 $7.74B $1.37B 17.65%
2022-09-30 $7.66B $1.30B 17.01%
2022-06-30 $7.59B $1.06B 14.02%
2022-03-31 $6.52B $0.87B 13.34%
2021-12-31 $5.48B $0.69B 12.66%
2021-09-30 $4.36B $0.55B 12.56%
2021-06-30 $3.19B $0.51B 16.05%
2021-03-31 $2.94B $0.47B 16.02%
2020-12-31 $2.80B $0.46B 16.37%
2020-09-30 $2.76B $0.46B 16.65%
2020-06-30 $2.77B $0.48B 17.40%
2020-03-31 $2.85B $0.52B 18.42%
2019-12-31 $2.81B $0.53B 18.75%
2019-09-30 $2.76B $0.50B 18.27%
2019-06-30 $2.70B $0.49B 17.97%
2019-03-31 $2.65B $0.46B 17.20%
2018-12-31 $2.60B $0.44B 16.95%
2018-09-30 $2.37B $0.43B 18.09%
2018-06-30 $2.16B $0.42B 19.24%
2018-03-31 $1.95B $0.41B 20.97%
2017-12-31 $1.76B $0.40B 22.70%
2017-09-30 $1.74B $0.39B 22.61%
2017-06-30 $1.72B $0.38B 22.35%
2017-03-31 $1.70B $0.38B 22.38%
2016-12-31 $1.67B $0.37B 22.26%
2016-09-30 $1.64B $0.36B 22.14%
2016-06-30 $1.61B $0.36B 22.11%
2016-03-31 $1.59B $0.35B 22.04%
2015-12-31 $1.58B $0.34B 21.59%
2015-09-30 $1.56B $0.32B 20.17%
2015-06-30 $1.56B $0.30B 19.42%
2015-03-31 $1.54B $0.28B 18.22%
2014-12-31 $1.50B $0.25B 16.89%
2014-09-30 $1.46B $0.23B 15.70%
2014-06-30 $1.41B $0.20B 14.25%
2014-03-31 $1.37B $0.18B 13.29%
2013-12-31 $1.44B $0.27B 18.71%
2013-09-30 $1.39B $0.26B 18.45%
2013-06-30 $1.34B $0.24B 18.15%
2013-03-31 $1.28B $0.23B 17.86%
2012-12-31 $1.21B $0.20B 16.67%
2012-09-30 $1.15B $0.19B 16.45%
2012-06-30 $1.10B $0.17B 15.31%
2012-03-31 $1.06B $0.17B 15.66%
2011-12-31 $1.02B $0.15B 15.05%
2011-09-30 $1.01B $0.26B 25.49%
2011-06-30 $1.00B $0.27B 27.41%
2011-03-31 $0.99B $0.28B 28.57%
2010-12-31 $0.99B $0.22B 21.90%
2010-09-30 $0.99B $0.14B 13.69%
2010-06-30 $0.98B $0.15B 15.09%
2010-03-31 $0.98B $0.15B 15.46%
2009-12-31 $0.89B $0.15B 16.80%
Sector Industry Market Cap Revenue
Medical Medical Services $18.679B $8.120B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00